The DOI matches its Crossref record; 103 of the 103 references it cites were found in a registry or an index.
Aspirin and cancer risk: a quantitative review to 2011
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.
(2009) · PubMed Central · Cited by 44,859
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
Quantifying heterogeneity in a meta‐analysis
Higgins, J. P. T., & Thompson, S. G. (2002) · Statistics in Medicine · doi:10.1002/sim.1186 · Cited by 36,763
QUANTITATIVE METHODS IN THE REVIEW OF EPIDEMIOLOGIC LITERATURE1
GREENLAND, S. (1987) · Epidemiologic Reviews · doi:10.1093/oxfordjournals.epirev.a036298 · Cited by 1,644 · cited 1×
“10) [28] and quantified the inconsistencies using the I(2) statistic, which represents the percentage of the total variation across studies that is attributable to”
Rothwell, P. M., Fowkes, F. G. R., Belch, J. F., Ogawa, H., Warlow, C. P., & Meade, T. W. (2011) · The Lancet · doi:10.1016/s0140-6736(10)62110-1 · Cited by 1,497
Thun, M. J., Henley, S. J., & Patrono, C. (2002) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/94.4.252 · Cited by 1,433
A Randomized Trial of Aspirin to Prevent Colorectal Adenomas
Baron, J. A., Cole, B. F., Sandler, R. S., Haile, R. W., Ahnen, D., Bresalier, R., McKeown-Eyssen, G., Summers, R. W., Rothstein, R., Burke, C. A., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021735 · Cited by 1,416
Rothwell, P. M., Wilson, M., Elwin, C.-E., Norrving, B., Algra, A., Warlow, C. P., & Meade, T. W. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61543-7 · Cited by 1,351 · cited 1×
“Additionally, a pooled analysis of four RCTs of aspirin use for the prevention of cardiovascular diseases showed a reduction in colorectal cancer incidence and mortality, but only after a latency period of at least 10 years and for treatments of ‡5 years [24, 25].”
MethodPublication bias in meta-analysis its causes and consequences
Thornton, A. (2000) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(99)00161-4 · Cited by 1,291 · cited 1×
“Publication bias was evaluated using funnel plots and quantified by the Egger’s and Begg’s test [30, 31].”
MethodSandler, R. S., Halabi, S., Baron, J. A., Budinger, S., Paskett, E., Keresztes, R., Petrelli, N., Pipas, J. M., Karp, D. D., Loprinzi, C. L., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021633 · Cited by 1,136
Epidemiology of Renal Cell Carcinoma
Padala, S. A., Barsouk, A., Thandra, K. C., Saginala, K., Mohammed, A., Vakiti, A., Rawla, P., & Barsouk, A. (2020) · World Journal of Oncology · doi:10.14740/wjon1279 · Cited by 1,058
Burn, J., Gerdes, A.-M., Macrae, F., Mecklin, J.-P., Moeslein, G., Olschwang, S., Eccles, D., Evans, D. G., Maher, E. R., Bertario, L., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)61049-0 · Cited by 952
Aspirin use and risk of fatal cancer.
Thun, M. J., Namboodiri, M. M., Calle, E. E., Flanders, W. D., & Heath, C. W. (1993) · PubMed · Cited by 870
Cook, N. R., Lee, I.-M., Gaziano, J. M., Gordon, D., Ridker, P. M., Manson, J. E., Hennekens, C. H., & Buring, J. E. (2005) · JAMA · doi:10.1001/jama.294.1.47 · Cited by 796
Cyclooxygenase-2 Inhibitors in Tumorigenesis (Part I)
Taketo, M. M. (1998) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/90.20.1529 · Cited by 757
Aspirin Use and Lung, Colon, and Breast Cancer Incidence in a Prospective Study
Schreinemachers, D. M., & Everson, R. B. (1994) · Epidemiology · doi:10.1097/00001648-199403000-00003 · Cited by 736
Cuzick, J., Otto, F., Baron, J. A., Brown, P. H., Burn, J., Greenwald, P., Jankowski, J., La Vecchia, C., Meyskens, F., Senn, H. J., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70035-x · Cited by 714
Self-citationIncidence of Cancer Among Patients With Rheumatoid Arthritis
Gridley, G., McLaughlin, J. K., Ekbom, A., Klareskog, L., Adami, H.-O., Hacker, D. G., Hoover, R., & Fraumeni, J. F. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.4.307 · Cited by 581
Long-term Use of Aspirin and Nonsteroidal Anti-inflammatory Drugs and Risk of Colorectal Cancer
Chan, A. T. (2005) · JAMA · doi:10.1001/jama.294.8.914 · Cited by 478
Aspirin for the Chemoprevention of Colorectal Adenomas: Meta-analysis of the Randomized Trials
Cole, B. F., Logan, R. F., Halabi, S., Benamouzig, R., Sandler, R. S., Grainge, M. J., Chaussade, S., & Baron, J. A. (2009) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djn485 · Cited by 476
Excess risk of lymphomas, leukemia and myeloma in patients with rheumatoid arthritis
Isomäki, H. A., Hakulinen, T., & Joutsenlahti, U. (1978) · Journal of Chronic Diseases · doi:10.1016/0021-9681(78)90071-1 · Cited by 433
Farrow, D. C., Vaughan, T. L., Hansten, P. D., et al. (1998) · PubMed · Cited by 416
Harris, R. E., Chlebowski, R. T., Jackson, R. D., Frid, D. J., Ascenseo, J. L., Anderson, G. L., Loar, A., Rodabough, R. J., White, E., & McTiernan, A. (2003) · PubMed · Cited by 411
McQuaid, K. R., & Laine, L. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2005.10.039 · Cited by 409
Cyclooxygenase-2 Inhibitors in Tumorigenesis (Part II)
Taketo, M. M. (1998) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/90.21.1609 · Cited by 399
Aspirin and Folic Acid for the Prevention of Recurrent Colorectal Adenomas
Logan, R. F. A., Grainge, M. J., Shepherd, V. C., Armitage, N. C., & Muir, K. R. (2008) · Gastroenterology · doi:10.1053/j.gastro.2007.10.014 · Cited by 398
Aspirin use and chronic diseases: a cohort study of the elderly.
Paganini-Hill, A., Chao, A., Ross, R. K., & Henderson, B. E. (1989) · BMJ · doi:10.1136/bmj.299.6710.1247 · Cited by 396
Benamouzig, R., Deyra, J., Martin, A., Girard, B., Jullian, E., Piednoir, B., Couturier, D., Coste, T., Little, J., & Chaussade, S. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00887-4 · Cited by 395
García Rodríguez, L. A., & Huerta-Alvarez, C. (2001) · Epidemiology · doi:10.1097/00001648-200101000-00015 · Cited by 359
A Large Cohort Study of Long-Term Daily Use of Adult-Strength Aspirin and Cancer Incidence
Jacobs, E. J., Thun, M. J., Bain, E. B., Rodriguez, C., Henley, S. J., & Calle, E. E. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djk132 · Cited by 322
Aspirin Use and Colorectal Cancer: Post-Trial Follow-up Data from the Physicians' Health Study
Sturmer, T., Glynn, R. J., Lee, I.-M., Manson, J. E., Buring, J. E., & Hennekens, C. H. (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-128-9-199805010-00003 · Cited by 294
Effect of aspirin and NSAIDs on risk and survival from colorectal cancer
Din, F. V. N., Theodoratou, E., Farrington, S. M., Tenesa, A., Barnetson, R. A., Cetnarskyj, R., Stark, L., Porteous, M. E., Campbell, H., & Dunlop, M. G. (2010) · Gut · doi:10.1136/gut.2009.203000 · Cited by 284
Aspirin, salicylates, and cancer
Elwood, P. C., Gallagher, A. M., Duthie, G. G., Mur, L. A., & Morgan, G. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60243-9 · Cited by 282
Aspirin use, cancer, and polyps of the large bowel
Suh, O., Mettlin, C., & Petrelli, N. J. (1993) · Cancer · doi:10.1002/1097-0142(19930815)72:4<1171::aid-cncr2820720407>3.0.co;2-d · Cited by 276
Seshasai, S. R. K. (2012) · Archives of Internal Medicine · doi:10.1001/archinternmed.2011.628 · Cited by 272
Terry, M. B. (2004) · JAMA · doi:10.1001/jama.291.20.2433 · Cited by 271
Aspirin Dose and Duration of Use and Risk of Colorectal Cancer in Men
Chan, A. T., Giovannucci, E. L., Meyerhardt, J. A., Schernhammer, E. S., Wu, K., & Fuchs, C. S. (2008) · Gastroenterology · doi:10.1053/j.gastro.2007.09.035 · Cited by 242
Breast Cancer and Use of Nonsteroidal Anti-inflammatory Drugs: A Meta-analysis
Takkouche, B., Regueira-Mendez, C., & Etminan, M. (2008) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn324 · Cited by 215
Non-steroidal anti-inflammatory drugs and bladder cancer prevention
Castelao, J. E., Yuan, J.-M., Gago-Dominguez, M., Yu, M. C., & Ross, R. K. (2000) · British Journal of Cancer · doi:10.1054/bjoc.1999.1106 · Cited by 214
Reduction in the risk of human breast cancer by selective cyclooxygenase-2 (COX-2) inhibitors
Harris, R. E., Beebe-Donk, J., & Alshafie, G. A. (2006) · BMC Cancer · doi:10.1186/1471-2407-6-27 · Cited by 214
Jouzeau, J.-Y., Terlain, B., Abid, A., Nédélec, E., & Netter, P. (1997) · Drugs · doi:10.2165/00003495-199753040-00003 · Cited by 192
Jacobs, E. J., Rodriguez, C., Mondul, A. M., Connell, C. J., Henley, S. J., Calle, E. E., & Thun, M. J. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji173 · Cited by 185
Prospective Study of Regular Aspirin Use and the Risk of Breast Cancer
Egan, K. M., Stampfer, M. J., Giovannucci, E., Rosner, B. A., & Colditz, G. A. (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.14.988 · Cited by 183
Abnet, C. C., Freedman, N. D., Kamangar, F., Leitzmann, M. F., Hollenbeck, A. R., & Schatzkin, A. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6604880 · Cited by 181
Nonsteroidal antiinflammatory drug use and reduced risk of large bowel carcinoma
Rosenberg, L., Louik, C., & Shapiro, S. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19980615)82:12<2326::aid-cncr5>3.0.co;2-q · Cited by 161
Aspirin and cancer: has aspirin been overlooked as an adjuvant therapy?
Langley, R. E., Burdett, S., Tierney, J. F., Cafferty, F. H., Parmar, M., & Venning, G. R. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.289 · Cited by 151
Epidemiologic Aspects of Renal Cell Carcinoma
McLaughlin, J. K., Lipworth, L., & Tarone, R. E. (2006) · Seminars in Oncology · doi:10.1053/j.seminoncol.2006.06.010 · Cited by 146
Nonsteroidal Anti-Inflammatory Drug Use and Breast Cancer Risk by Stage and Hormone Receptor Status
Marshall, S. F., Bernstein, L., Anton‐Culver, H., Deapen, D., Horn‐Ross, P. L., Mohrenweiser, H. W., Peel, D. A., Pinder, R., Purdie, D. M., Reynolds, P., et al. (2005) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dji140 · Cited by 135
Aspirin use and mortality from cancer in a prospective cohort study.
Ratnasinghe, L. D., Graubard, B. I., Kahle, L., Tangrea, J. A., Taylor, P. R., & Hawk, E. (2004) · PubMed · Cited by 124
Use of nonsteroidal anti‐inflammatory drugs and prostate cancer risk: A meta‐analysis
Mahmud, S. M., Franco, E. L., & Aprikian, A. G. (2010) · International Journal of Cancer · doi:10.1002/ijc.25186 · Cited by 122
Aspirin and cancer risk: an updated quantitative review to 2005
Bosetti, C., Gallus, S., & Vecchia, C. L. (2006) · Cancer Causes & Control · doi:10.1007/s10552-006-0033-7 · Cited by 118
Self-citationAssociation of aspirin and nonsteroidal anti-inflammatory drug use with breast cancer.
Johnson, T., Anderson, K. E., Lazovich, D., & Folsom, A. R. (2002) · PubMed · Cited by 118
Bardia, A., Olson, J. E., Vachon, C. M., Lazovich, D., Vierkant, R. A., Wang, A. H., Limburg, P. J., Anderson, K. E., & Cerhan, J. R. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-1074-x · Cited by 111
Regular use of analgesics is a risk factor for renal cell carcinoma
Gago-Domínguez, M., Yuan, J.-M., Castelao, J. E., Ross, R. K., & Yu, M. C. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690728 · Cited by 110
Long-term Aspirin Use and Mortality in Women
Chan, A. T., Manson, J. E., Feskanich, D., Stampfer, M. J., Colditz, G. A., & Fuchs, C. S. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.6.562 · Cited by 108
Gierach, G. L., Lacey, J. V., Schatzkin, A. G., Leitzmann, M. F., Richesson, D. A., Hollenbeck, A. R., & Brinton, L. A. (2008) · Breast Cancer Research · doi:10.1186/bcr2089 · Cited by 106
Heavy Phenacetin Use and Bladder Cancer in Women Aged 20 to 49 Years
Piper, J. M., Tonascia, J. A., & Matanoski, G. M. (1985) · New England Journal of Medicine · doi:10.1056/nejm198508013130504 · Cited by 106
Association between NSAIDs use and breast cancer risk: a systematic review and meta-analysis
Zhao, Y., Zhu, S., Li, X., Wang, F., Hu, F., Li, D., Zhang, W., & Li, X. (2008) · Breast Cancer Research and Treatment · doi:10.1007/s10549-008-0228-6 · Cited by 101
Nonsteroidal anti-inflammatory drug use and breast cancer risk.
Cotterchio, M., Kreiger, N., Sloan, M., & Steingart, A. B. (2001) · PubMed · Cited by 100
Phenacetin‐Containing Analgesics and Cancer of the Bladder or Renal Pelvis in Women
McCredie, M. R. E., Stewart, J. H., Ford, J. M., et al. (1983) · British Journal of Urology · doi:10.1111/j.1464-410x.1983.tb06561.x · Cited by 95
Salinas, C. A., Kwon, E. M., FitzGerald, L. M., Feng, Z., Nelson, P. S., Ostrander, E. A., Peters, U., & Stanford, J. L. (2010) · American Journal of Epidemiology · doi:10.1093/aje/kwq175 · Cited by 94
Cancer Chemoprevention by Cyclooxygenase 2 (COX-2) Blockade: Results of case control studies
Harris, R. E., Beebe-Donk, J., & Alshafie, G. A. (2007) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/1-4020-5688-5_9 · Cited by 91
Risk of breast cancer among users of aspirin and other anti-inflammatory drugs
Rodríguez, L. A. G., & González‐Pérez, A. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6602003 · Cited by 91
Vinogradova, Y., Hippisley‐Cox, J., Coupland, C. A. C., & Logan, R. F. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.05.023 · Cited by 91
Aspirin, NSAIDs, and Colorectal Cancer: Possible Involvement in an Insulin-Related Pathway
Slattery, M. L., Samowitz, W. S., Hoffman, M. D., Ne, K., Levin, T. R., & Neuhausen, S. L. (2004) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.538.13.4 · Cited by 85
Zhang, Y., Coogan, P. F., Palmer, J. R., et al. (2005) · American Journal of Epidemiology · doi:10.1093/aje/kwi182 · Cited by 82
Aspirin use and breast cancer risk: a meta-analysis
Luo, T., Yan, H., He, P., Luo, Y., Yang, Y.-F., & Zheng, H. Y. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1747-0 · Cited by 80
Harris, R. E., Beebe-Donk, J., & Alshafie, G. A. (2008) · BMC Cancer · doi:10.1186/1471-2407-8-237 · Cited by 76
Inverse Association between Nonsteroidal Anti-inflammatory Drugs and Prostate Cancer
Rodríguez, L. A. G., & González‐Pérez, A. (2004) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.649.13.4 · Cited by 74
Dosage, duration and timing of nonsteroidal antiinflammatory drug use and risk of prostate cancer
Perron, L., Bairati, I., Moore, L., & Meyer, F. (2003) · International Journal of Cancer · doi:10.1002/ijc.11250 · Cited by 68
Aspirin Use and the Risk of Gastric Cancer: A Meta-Analysis
Yang, P., Zhou, Y., Chen, B., Wan, H.-W., Jia, G., Bai, H.-L., & Wu, X. (2009) · Digestive Diseases and Sciences · doi:10.1007/s10620-009-0915-0 · Cited by 68
Association of Regular Aspirin Use and Breast Cancer Risk
Swede, H., Mirand, A. L., Menezes, R. J., & Moysich, K. B. (2005) · Oncology · doi:10.1159/000084818 · Cited by 67
Nonsteroidal Antiinflammatory Drugs and Breast Cancer Risk: The Multiethnic Cohort
Gill, J. K., Maskarinec, G., Wilkens, L. R., Pike, M. C., Henderson, B. E., & Kolonel, L. N. (2007) · American Journal of Epidemiology · doi:10.1093/aje/kwm195 · Cited by 66
Mahipal, A., Anderson, K. E., Limburg, P. J., & Folsom, A. R. (2006) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-05-0674 · Cited by 62
NSAID use and breast cancer risk in the VITAL cohort
Ready, A., Velicer, C. M., McTiernan, A., & White, E. (2007) · Breast Cancer Research and Treatment · doi:10.1007/s10549-007-9665-x · Cited by 61
A Case–Control Study of Levothyroxine and the Risk of Colorectal Cancer
Rennert, G., Rennert, H. S., Pinchev, M., & Gruber, S. B. (2010) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djq042 · Cited by 59
Aspirin and Nonsteroidal Anti-inflammatory Drug Use and Risk of Pancreatic Cancer: A Meta-analysis
Larsson, S. C., Giovannucci, E. L., Bergkvist, L., & Wolk, A. (2006) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-06-0574 · Cited by 58
Brasky, T. M., Bonner, M. R., Moysich, K. B., Ambrosone, C. B., Nie, J., Tao, M. H., Edge, S. B., Kallakury, B., Marian, C., Goerlitz, D. S., et al. (2011) · Cancer Causes & Control · doi:10.1007/s10552-011-9769-9 · Cited by 57
FRIEDMAN, G. D., Coates, A. O., Potter, J. D., & Slattery, M. L. (1998) · Pharmacoepidemiology and Drug Safety · doi:10.1002/(sici)1099-1557(199803/04)7:2<99::aid-pds320>3.0.co;2-0 · Cited by 57
Mangiapane, S., Blettner, M., & Schlattmann, P. (2007) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1503 · Cited by 57
Nonsteroidal anti-inflammatory drug use and breast cancer risk: a Danish cohort study
Friis, S., Thomassen, L., Sørensen, H. T., Tjønneland, A. M., Overvad, K., Cronin-Fenton, D. P., Vogel, U. B., McLaughlin, J. K., Blot, W. J., & Olsen, J. H. (2008) · European Journal of Cancer Prevention · doi:10.1097/cej.0b013e3282b6fd55 · Cited by 56
Eliassen, A. H., Chen, W. Y., Spiegelman, D. L., Willett, W. C., Hunter, D. J., & Hankinson, S. E. (2009) · Archives of Internal Medicine · doi:10.1001/archinternmed.2008.537 · Cited by 55
Epidemiology of Renal Cell Carcinoma
Kümmerlin, I. P. E. D., Laguna, M. P., de la Rosette, J. J. M. C. H., & Bossuyt, P. M. (2008) · Springer eBooks · doi:10.1007/978-1-84628-763-3_1 · Cited by 55
Mahmud, S. M., Franco, E. L., Turner, D., Platt, R. W., Beck, P., Skarsgard, D., Tonita, J. M., Sharpe, C. R., & Aprikian, A. G. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016412 · Cited by 53
Nonsteroidal Antiinflammatory Drug Use and Breast Cancer Risk: Subgroup Findings
Kirsh, V. A., Kreiger, N., Cotterchio, M., Sloan, M., & Theis, B. (2007) · American Journal of Epidemiology · doi:10.1093/aje/kwm216 · Cited by 52
Nonsteroidal Antiinflammatory Drugs and Risk of Gastric Adenocarcinoma: The Multiethnic Cohort Study
Epplein, M., Nomura, A. M. Y., Wilkens, L. R., Henderson, B. E., & Kolonel, L. N. (2009) · American Journal of Epidemiology · doi:10.1093/aje/kwp162 · Cited by 51
Fortuny, J., Kogevinas, M., García‐Closas, M., Real, F. X., Tardón, A., García-Closas, R., Serra, C., Carrato, A., Lloreta, J., Rothman, N., et al. (2006) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-06-0038 · Cited by 50
Aspirin and cancer risk: an update to 2001
Bosetti, C., Gallus, S., & Vecchia, C. L. (2002) · European Journal of Cancer Prevention · doi:10.1097/00008469-200212000-00005 · Cited by 50
Self-citationFortuny, J., Kogevinas, M., Zens, M. S., Schned, A. R., Andrew, A. S., Heaney, J., Kelsey, K. T., & Karagas, M. R. (2007) · BMC Urology · doi:10.1186/1471-2490-7-13 · Cited by 49
Friis, S., Poulsen, A. H., Sørensen, H. T., Tjønneland, A. M., Overvad, K., Vogel, U. B., McLaughlin, J. K., Blot, W. J., & Olsen, J. H. (2009) · Cancer Causes & Control · doi:10.1007/s10552-008-9286-7 · Cited by 48
Dhillon, P. K., Kenfield, S. A., Stampfer, M. J., & Giovannucci, E. L. (2010) · International Journal of Cancer · doi:10.1002/ijc.25811 · Cited by 48
Sansbury, L. B., Millikan, R. C., Schroeder, J. C., Moorman, P. G., North, K. E., & Sandler, R. S. (2005) · American Journal of Epidemiology · doi:10.1093/aje/kwi248 · Cited by 48
Brasky, T. M., Bonner, M. R., Moysich, K. B., Ambrosone, C. B., Nie, J., Tao, M. H., Edge, S. B., Kallakury, B., Marian, C., Trevisan, M., et al. (2010) · Cancer Causes & Control · doi:10.1007/s10552-010-9579-5 · Cited by 46
Capurso, G., Schünemann, H. J., Terrenato, I., MORETTI, A., Koch, M., Muti, P. C., Capurso, L., & Fave, G. D. (2007) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2007.03495.x · Cited by 45
Long-term aspirin use and colorectal cancer risk: a cohort study in Sweden
Larsson, S. C., Giovannucci, E. L., & Wolk, A. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603442 · Cited by 42
A Prospective Study of Aspirin Use and the Risk of Gastrointestinal Bleeding in Men
Huang, E. S., Strate, L. L., Ho, W. W., Lee, S. S., & Chan, A. T. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015721 · Cited by 41
Aspirin use and risk for lung cancer: a meta-analysis
Oh, S., Myung, S., Park, J. Y., Lee, C. M., & Kwon, H. T. (2011) · Annals of Oncology · doi:10.1093/annonc/mdq779 · Cited by 37
Regular aspirin use and breast cancer risk in US Black Women
Bosco, J. L. F., Palmer, J. R., Boggs, D. A., Hatch, E. E., & Rosenberg, L. A. (2011) · Cancer Causes & Control · doi:10.1007/s10552-011-9832-6 · Cited by 33
The Association between Aspirin Use and the Incidence of Colorectal Cancer in Women
Allison, M., Garland, C., Chlebowski, R. T., Criqui, M. H., Langer, R., Wu, L., Roy, H. K., McTiernan, A., & Kuller, L. H. (2006) · American Journal of Epidemiology · doi:10.1093/aje/kwj250 · Cited by 31
Fiorucci, S., & Antonelli, E. (2001) · Digestive and Liver Disease · doi:10.1016/s1590-8658(01)80152-3 · Cited by 22
Kim, S. Y. H., Martin, C., Galanko, J., Woosley, J. T., Schroeder, J. C., Keku, T. O., Satia, J. A., Halabi, S., & Sandler, R. S. (2008) · American Journal of Epidemiology · doi:10.1093/aje/kwn255 · Cited by 13
Cited by
Global patterns and trends in colorectal cancer incidence and mortality
Arnold, M., Sierra, M. S., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2017) · Gut · doi:10.1136/gutjnl-2015-310912 · Cited by 5,228
Brenner, H., Kloor, M., & Pox, C. P. (2014) · The Lancet · doi:10.1016/s0140-6736(13)61649-9 · Cited by 2,762
Gastric Cancer: Descriptive Epidemiology, Risk Factors, Screening, and Prevention
Karimi, P., Islami, F., Anandasabapathy, S., Freedman, N. D., & Kamangar, F. (2014) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-13-1057 · Cited by 1,879
Pimentel-Nunes, P., Libânio, D., Marcos-Pinto, R., Areia, M., Leja, M., Esposito, G., Garrido, M., Kikuste, I., Megraud, F., Matysiak-Budnik, T., et al. (2019) · Endoscopy · doi:10.1055/a-0859-1883 · Cited by 993
Breast cancer as a systemic disease: a view of metastasis
Redig, A. J., & McAllister, S. S. (2013) · Journal of Internal Medicine · doi:10.1111/joim.12084 · Cited by 709
Metadata
- Authors
- Bosetti, C., Rosato, V., Gallus, S., Cuzick, J., & La Vecchia, C.
- Venue
- Annals of Oncology
- Publisher
- Elsevier BV
- Published
- 2012-06
- Volume
- 23
- Issue
- 6
- Pages
- 1403-1415
- ISSN
- 0923-7534 (ISSN-L)
- OpenAlex
- W2158402121
- Cited by
- 297
- References
- 103
- FWCI
- 25.39
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.